Literature DB >> 16097560

The MRC randomised-controlled trial of interferon-alpha, interleukin-2 and 5-fluorouracil vs interferon-alpha alone in patients with advanced renal cell carcinoma (RE04): rationale and progress.

J M G Larkin, M E Gore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097560     DOI: 10.1016/j.clon.2005.03.007

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  1 in total

1.  Renal cell carcinoma and the use of sorafenib.

Authors:  James Mg Larkin; Tim Eisen
Journal:  Ther Clin Risk Manag       Date:  2006-03       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.